ETHYNODIOL
Ethinyl Estradiol / Ethynodiol, Kelnor, Lo-malmorede, Malmorede, Ovulen, Zovia (ethynodiol) is a small molecule pharmaceutical. Ethynodiol was first approved as Demulen 1/50-21 on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Combinations
Ethynodiol ethinyl estradiol, Kelnor, Lo-malmorede, Malmorede, Zovia (discontinued: Demulen, Ovulen, Zovia)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ethinyl estradiol
+
Ethynodiol diacetate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DEMULEN 1/50-21 | G.D. Searle | N-016927 DISCN | 1982-01-01 | 1 products |
| DEMULEN 1/50-28 | G.D. Searle | N-016936 DISCN | 1982-01-01 | 1 products |
| DEMULEN 1/35-28 | G.D. Searle | N-018160 DISCN | 1982-01-01 | 1 products |
| DEMULEN 1/35-21 | G.D. Searle | N-018168 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Ethynodiol diacetate
+
Mestranol
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| OVULEN | G.D. Searle | N-016029 DISCN | 1982-01-01 | 1 products |
| OVULEN-21 | G.D. Searle | N-016029 DISCN | 1982-01-01 | 1 products |
| OVULEN-28 | G.D. Searle | N-016705 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| ethynodiol diacetate and ethinyl estradiol | ANDA | 2021-12-18 |
| kelnor 1/35 | ANDA | 2023-02-04 |
| kelnor 1/50 | ANDA | 2021-12-17 |
| valtya 1/35 | ANDA | 2025-02-05 |
| valtya 1/50 | ANDA | 2025-02-05 |
| zovia 1/35 | ANDA | 2024-06-01 |
| zovia 1/35e-28 zovia 1/50e-28 | ANDA | 2012-04-13 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
G: Genito urinary system and sex hormones
— G03: Sex hormones and modulators of the genital system
— G03A: Hormonal contraceptives for systemic use
— G03AA: Progestogens and estrogen systemic contraceptives, fixed combinations
— G03AA01: Etynodiol and ethinylestradiol
— G03D: Progestogen sex hormones and modulators of the genital system
— G03DC: Estren derivatives, sex hormones and modulators of the genital system
— G03DC06: Etynodiol
— G03F: Progestogens and estrogens in combination
— G03FA: Progestogens and estrogens, fixed combinations
— G03FA06: Etynodiol and estrogen
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | ETHYNODIOL |
| INN | etynodiol |
| Description | Ethynodiol is a 17beta-hydroxy steroid, a 3beta-hydroxy steroid and a terminal acetylenic compound. It has a role as a progestin. |
| Classification | Small molecule |
| Drug class | Progestin; Progestogen |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C[C@@H](O)CC[C@@H]4[C@H]3CC[C@@]21C |
Identifiers
| PDB | — |
| CAS-ID | 1231-93-2 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201406 |
| ChEBI ID | 50785 |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 9E01C36A9S (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Ethynodiol
+
Ethinyl estradiol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 332 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
78 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use